Induced Hypothermia clinical trials at UCSF
2 research studies open to eligible people
Induced hypothermia involves cooling the body to assist medical recovery. UCSF's trials are examining if longer cooling periods improve outcomes following cardiac arrest. Trials include research on how this cooling impacts young patients' brain health after heart arrest.
Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients
open to eligible people ages 18 years and up
A multicenter, randomized, adaptive allocation clinical trial to determine if increasing durations of induced hypothermia are associated with an increasing rate of good neurological outcomes and to identify the optimal duration of induced hypothermia for neuroprotection in comatose survivors of cardiac arrest.
San Francisco, California and other locations
Pediatric Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients (P-ICECAP)
open to eligible people ages up to 17 years
This is a multicenter trial to establish the efficacy of cooling and the optimal duration of induced hypothermia for neuroprotection in pediatric comatose survivors of cardiac arrest. The study team hypothesizes that longer durations of cooling may improve either the proportion of children that attain a good neurobehavioral recovery or may result in better recovery among the proportion already categorized as having a good outcome.
Oakland, California and other locations
Our lead scientists for Induced Hypothermia research studies include Patrick McQuillen, MD.
Last updated: